Experimental external irradiation of corneal neovascularization

被引:3
|
作者
Joussen, AM
Kruse, FE
Ötzel, D
Holz, FG
Debus, J
Rohrschneider, K
Völcker, HE
机构
[1] Univ Heidelberg, Augenklin, Heidelberg, Germany
[2] Univ Heidelberg, Klin Strahlentherapie, Heidelberg, Germany
来源
OPHTHALMOLOGE | 1999年 / 96卷 / 04期
关键词
corneal angiogenesis; radiation therapy; external irradiation;
D O I
10.1007/s003470050398
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The clinical effect of ionidizing radiation on ocular neovascularizations is controversial not only because of the variety of treatment modalities. The aim of our study was to investigate an experimental model which allows to evaluate radiation parameters and to study the mechanism of the inhibitory effect on neoangiogensis. Methods: Corneal angiogenesis was induced by use of a micropocket assay in NZW rabbits. Pellets with 500 ng bFGF in 2% methylcellulose were implanted into the stroma 2.0 mm from the limbus. initiation of vessel growth occurred on day 3. At this time radiation was performed with different doses (single dose of 15 to 30 Gy or fractionated 5 x 5 Gy) using a 6 MeV linear accelerator Vascular growth was quantified. Results: Irradiation with a total dose of 25 Gy applied in a fractionated regimen or as single-dose irradiation on the day of surgery or on day 6 after surgery did not significantly reduce neovascular growth. In contrast, postoperative radiation therapy on day 3 was able to reduce the area of ingrowing vessels significantly (P < 0.01). In spite of the relatively high dose there were no significant side effects during the observation period of 8 weeks. Conclusion: Our results show that single-dose radiation (greater than or equal to 25 Gy) is sufficient to inhibit the growth of corneal neovascularizations. With this model it might be possible to investigate parameters for th era py of ocular neovascularizations as well as the underlying mechanisms.
引用
收藏
页码:234 / 239
页数:8
相关论文
共 50 条
  • [31] Streptozotocin-induced diabetic mice exhibit reduced experimental choroidal neovascularization but not corneal neovascularization
    Liu, Gaoqin
    Chen, Lei
    Cai, Qinhua
    Wu, Hongya
    Chen, Zhigang
    Zhang, Xueguang
    Lu, Peirong
    MOLECULAR MEDICINE REPORTS, 2018, 18 (05) : 4388 - 4398
  • [32] PHTHALOCYANINE MEDIATED PHOTODYNAMIC THROMBOSIS OF EXPERIMENTAL CORNEAL NEOVASCULARIZATION - EFFECT OF PHTHALOCYANINE DOSE AND IRRADIATION ONSET TIME ON VASCULAR OCCLUSION RATE
    TSILIMBARIS, MK
    PALLIKARIS, IG
    NAOUMIDI, II
    VLAHONIKOLIS, IG
    TSAKALOF, AK
    LYDATAKI, SE
    LASERS IN SURGERY AND MEDICINE, 1994, 15 (01) : 19 - 31
  • [33] HISTOPATHOLOGY OF CORNEAL NEOVASCULARIZATION
    SCHANZLIN, DJ
    CYR, RJ
    FRIEDLAENDER, MH
    ARCHIVES OF OPHTHALMOLOGY, 1983, 101 (03) : 472 - 474
  • [34] Managements for Corneal Neovascularization
    Mohammadpour, Mehrdad
    CORNEA, 2013, 32 (11) : E190 - E190
  • [35] Drops for Corneal Neovascularization
    Das, Madhusmita
    Murthy, Somasheila
    OPHTHALMOLOGY, 2010, 117 (10) : 2042 - 2042
  • [36] PROSTAGLANDINS AND CORNEAL NEOVASCULARIZATION
    TONG, EY
    HUGHES, LA
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 872 - 872
  • [37] Bevacizumab for Corneal Neovascularization
    Jacobs, Deborah S.
    Lim, Mira
    Carrasquillo, Karen G.
    Rosenthal, Perry
    OPHTHALMOLOGY, 2009, 116 (03) : 592 - 593
  • [38] Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization
    Liu, Gaoqin
    Zhang, Wenpeng
    Xiao, Yanhui
    Lu, Peirong
    CURRENT EYE RESEARCH, 2015, 40 (09) : 891 - 901
  • [39] Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization
    Chen, Peng
    Yin, Hongmei
    Wang, Yao
    Mi, Jing
    He, Wenxiao
    Xie, Lixin
    Wang, Yiqiang
    MOLECULAR VISION, 2010, 16 (37): : 310 - 319
  • [40] Effect of subconjunctival bevacizurnab (Avastin) on experimental corneal neovascularization in guinea pigs
    Hurmeric, Volkan
    Mumcuoglu, Tarkan
    Erdurman, Cuneyt
    Kurt, Bident
    Dagli, Ozan
    Durukan, Ali H.
    CORNEA, 2008, 27 (03) : 357 - 362